SAN FRANCISCO,CA--(Marketwire - Jan 7, 2013) - Riverbed

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SAN FRANCISCO,CA--(Marketwire - Jan 7, 2013) - Riverbed Technology (NASDAQ: RVBD), the performance company, today announced that US Markerboard, the leader in online whiteboard and communication board retail, has deployed Riverbed® Stingray Aptimizer software to improve Web performance across its 12 e-commerce sites including US Markerboard, US Entrance Mats, and Brite Inc. US Markerboard's business is built on its fast, dependable, easy-to-use e-commerce site, competitive prices, and quality customer service. With the Stingray™ Aptimizer™ software deployment, the family owned e-commerce company improved customers' online shopping experience and increased customer loyalty resulting in a 25 percent conversion rate and an overall 15 percent increase in sales. Started in 1997 by a father and son team and based in Holbrook, Mass., US Markerboard is the premier online shopping destination for school, home, and office supplies including whiteboards, chalkboards, and bulletin boards. Launched as an alternative to local retailers by providing a wider range of products, the e-commerce site made the customer experience its top priority. As the company grew, so did the website's size and complexity with added features like multiple product views to create an experience similar to being "in-store" and real-time customer support via chat. In 2010, the company recognized the need for Web content optimization (WCO). Page loads were taking nine seconds and this poor performance was affecting sales. During peak traffic times, such as back to school shopping and holiday shopping, long load times can motivate the Web consumer to shop elsewhere. Also, the company knew it needed to increase its page speed to improve their Google search ranking. After evaluating multiple Web performance alternatives, US Markerboard chose Stingray Aptimizer software to accelerate Web content delivery and create the optimal customer experience. "Since we started the company, we have been committed to delivering the best online shopping experience for our customers, so they can shop easily and make purchases quickly," said Scott Newman, President and CEO of US Markerboard. "With Stingray Aptimizer software, we can deliver a rich customer experience, comparable to being in a brick-and-mortar store, while also delivering Web content fast. By combining competitive prices, a superior shopping experience, and customer service, our customers stay on the site longer and continue to return." Riverbed helped US Markerboard reduce page load times on average from nine seconds to three seconds, while also improving the company's Google search ranking. Overall, page views increased by 27 percent while page views per visit increased by eight percent. The Stingray Aptimizer deployment also lowered the bounce rate, where a site visitor leaves without viewing additional pages primarily due to session timeouts by the server, by 10 percent while the conversion rate has increased 25 percent. In business terms, the number of products per order has increased by 65 percent and average order value has increased by 15 percent, which, according to Newman, "is unheard of in e-commerce." "With the variety of products we offer, competitive pricing, strong customer service, and fast performance enabled by Stingray Aptimizer software, our customers can be assured they will continue to have a stress-free shopping experience -- we have no problem competing against the larger e-commerce sites," added Newman. Currently, US Markerboard's customer base primarily accesses the company's site from traditional Web browsers; however, should customers move to tablets and other mobile devices to shop the site, Newman is confident that the Stingray Aptimizer software will deliver a consistent experience. For more information about the Stingray product family including the Stingray Aptimize software, visit http://www.riverbed.com/us/products/stingray/. Additional Resources Facebook LinkedIn Riverbed Blog  Riverbed Community   Twitter (@Riverbed) YouTube Forward Looking Statements This press release contains forward-looking statements, including statements relating to the expected demand for Riverbed's products and services, statements regarding performance results of Riverbed solutions that may suggest likely or certain outcomes, and statements relating to Riverbed's ability to meet the needs of distributed organizations. These forward-looking statements involve risks and uncertainties, as well as assumptions that, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include our ability to react to trends and challenges in our business and the markets in which we operate; our ability to anticipate market needs or develop new or enhanced products to meet those needs; the adoption rate of our products; our ability to establish and maintain successful relationships with our distribution partners; our ability to compete in our industry; fluctuations in demand, sales cycles and prices for our products and services; shortages or price fluctuations in our supply chain; our ability to protect our intellectual property rights; general political, economic and market conditions and events; and other risks and uncertainties described more fully in our documents filed with or furnished to the Securities and Exchange Commission. More information about these and other risks that may impact Riverbed's business are set forth in our Form 10-Q filed with the SEC on October 25, 2012. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements. Any future product, feature or related specification that may be referenced in this release are for information purposes only and are not commitments to deliver any technology or enhancement. Riverbed reserves the right to modify future product plans at any time. About Riverbed Riverbed delivers performance for the globally connected enterprise. With Riverbed, enterprises can successfully and intelligently implement strategic initiatives such as virtualization, consolidation, cloud computing, and disaster recovery without fear of compromising performance. By giving enterprises the platform they need to understand, optimize and consolidate their IT, Riverbed helps enterprises to build a fast, fluid and dynamic IT architecture that aligns with the business needs of the organization. Additional information about Riverbed (NASDAQ: RVBD) is available at www.riverbed.com. Riverbed and any Riverbed product or service name or logo used herein are trademarks of Riverbed Technology, Inc. All other trademarks used herein belong to their respective owners. MEDIA CONTACTLori Bertelli Riverbed Technology 415.486.7909Email ContactINVESTOR RELATIONS CONTACTRenee Lyall Riverbed Technology 415-247-6353Email Contact

View More
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

TRIMEDX Earns Spot in 2024 Inspiring Workplaces Rankings

Updated Category News Views 62

TRIMEDX Recognized as One of the Top Inspiring Workplaces TRIMEDX, a leading name in clinical asset management, has proudly claimed the 30th spot on the 2024 Global Top 100 Inspiring Workplaces list. This esteemed recognition highlights organizations that prioritize people-first practices and create outstanding workplace environments. A Global Overview The Inspiring...

Continue Reading
Triumvirate Environmental Secures Major Investment Boost

Updated Category News Views 326

Triumvirate Environmental Announces $1.8 Billion Valuation Triumvirate Environmental, a prominent name in environmental services, has recently received a significant growth investment from Berkshire Partners, a well-respected private equity firm. This monumental partnership has led to Triumvirate being valued at $1.8 billion, a testament to its strong market position and...

Continue Reading
Investing in MSCI: A Journey Over 15 Years Explained

Updated Category News Views 198

The Growth of MSCI Over 15 Years MSCI (NYSE: MSCI) has demonstrated impressive performance over the past decade and a half, significantly outperforming the market. With an annualized return of 20.17%, MSCI has amassed a market capitalization of $43.82 billion. This remarkable performance speaks volumes about the company’s solid market positioning and timely strategic...

Continue Reading
Deckers Outdoor Surges in Premarket Trading After Strong Earnings Report

Updated Category News Views 243

Deckers Outdoor Impresses with Strong Financial Results Shares of Deckers Outdoor Corporation (NYSE: DECK) have recently experienced a notable increase in value. This uplift can be attributed to the company's impressive second-quarter earnings, which surpassed analysts' expectations. The casual footwear and apparel retailer reported revenue of $1.31 billion, significantly...

Continue Reading
Vitrolife Group Secures Major Financing Through Nordic Banks

Updated Category News Views 190

Vitrolife AB Strengthens Financial Backbone Vitrolife AB (publ) has taken a significant step towards enhancing its financial foundation by renewing and signing a loan agreement worth EUR 300 million. This strategic financial maneuver includes both a term loan and a revolving credit facility, aimed at refinancing existing debt while also providing resources for general...

Continue Reading